Lincomycin Injection is an antibiotic belonging to the lincosamide class, structurally related to clindamycin. It is mainly used for treating serious bacterial infections when other antibiotics (like penicillins) are not suitable.

Here are the key details:

1. Composition and Form:

• Active ingredient: Lincomycin hydrochloride.

• Supplied as a sterile solution in vials or ampoules.

• Intended for intramuscular (IM) or intravenous (IV) administration.

2. Mechanism of Action:

• Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.

• Primarily bacteriostatic (inhibits growth), but may be bactericidal at high concentrations against susceptible organisms.

3. Antimicrobial Spectrum:

• Effective against Gram-positive cocci (e.g., Staphylococcus aureus, Streptococcus pneumoniae).

• Active against some anaerobic bacteria.

• Not effective against most Gram-negative aerobic organisms.

4. Indications:

• Serious infections due to susceptible strains, such as:

  • Respiratory tract infections (pneumonia, lung abscess).

  • Skin and soft tissue infections.

  • Bone and joint infections (osteomyelitis, septic arthritis).

  • Septicemia caused by susceptible organisms.

• Often reserved for cases where penicillin or other antibiotics cannot be used (e.g., allergy, resistance).

5. Administration:

• Can be given IM or IV (slow infusion).

• Dosage depends on infection severity, site, and patient’s condition.

• Must be used under medical supervision with monitoring.

6. Side Effects:

• Gastrointestinal: nausea, vomiting, diarrhea.

• Serious: pseudomembranous colitis (caused by Clostridioides difficile overgrowth).

• Allergic reactions: rash, urticaria, pruritus, rare anaphylaxis.

• Pain or irritation at injection site.

• Elevated liver enzymes or abnormal kidney function tests in some patients.

7. Contraindications:

• Known hypersensitivity to lincomycin or clindamycin.

• Previous history of antibiotic-associated colitis.

8. Precautions:

• Use cautiously in patients with liver or kidney impairment (dose adjustment may be required).

• Monitor for diarrhea during and after therapy (risk of C. difficile colitis).

• Avoid concomitant use with macrolides or chloramphenicol (antagonistic action).

• Reserved for serious infections due to risk of severe side effects.

9. Storage:

• Store in a cool, dry place, away from light.

• Single-use vials should be used immediately after opening.